PMDA — authorised 26 June 2012
- Marketing authorisation holder: Astellas Pharma Inc.
- Status: approved
PMDA authorised Firmagon on 26 June 2012
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 26 June 2012.
Astellas Pharma Inc. holds the Japanese marketing authorisation.